InvestorsHub Logo
icon url

WHELANer

01/17/18 9:05 AM

#120345 RE: srinsocal #120344

Why was NURO at CES giving opioid presentation while Keith the minor leaguer was asleep at the wheel ?
icon url

speakhim

01/17/18 10:00 AM

#120349 RE: srinsocal #120344

Yes tens as been established and well know in the public for many years. The actipatch and it’s separate and superior tech will have to be in public eye for some time for more acceptance in use by the masses. How long? Not as long as it took tens...
Once chiropractors pick up the actipatch and start passing them out and actipatch gets on shelf in stores more, then actipatch will swallow the market share up quickly. GSK is into tens right now because it’s not a threat to its own products. It’s all about marketing.
icon url

Simpsonly

01/17/18 11:26 AM

#120359 RE: srinsocal #120344

Too funny - $26 Million paid by GSK to NURO for its $250 TENS device????
That must be the up-front non-exclusive Distributor fee srin or perhaps the cost to acquire a couple of percentage points? If that is actually the acquisition price of the deal to buy the IP, then, to me, it’s a fire sale price and NURO bailed! And fantastic news for BIEL which owns the patented IP for the only miniaturized SWT pain management device in earth that FDA has cleared as efficacious, safe and totally without side-effects. Isn’t the truth a wonderful thing? What a great day for BIEL!